Cancer A-Z
Cancer types, listed alphabetically.
17 entries
B
- Bladder Cancer
Urothelial cancers differ in depth of invasion and molecular profile.
Read more about Bladder Cancer- Brain Tumours
Central nervous system tumour classification now integrates molecular features with histology.
Read more about Brain Tumours- Breast Cancer
Breast cancer is biologically diverse. Receptor status and proliferation markers, along with molecular findings, contribute to how the disease is understood and managed.
Read more about Breast CancerRelated:Molecular testingHormone therapyAntibody-drug conjugates
C
- Colorectal Cancer
Colorectal cancer behaviour varies by tumour location, pathology and molecular profile.
Read more about Colorectal Cancer
G
- Gastric Cancer
Gastric and gastro-oesophageal cancers vary in pathology and molecular characteristics.
Read more about Gastric Cancer
H
- Haematological Malignancies
Leukaemias, lymphomas and myeloma are classified using morphology, immunophenotype and molecular findings.
Read more about Haematological Malignancies- Head & Neck Cancer
Head and neck cancers vary by site, viral association and pathology.
Read more about Head & Neck Cancer
K
- Kidney Cancer
Renal cell carcinoma includes several subtypes with distinct biology.
Read more about Kidney Cancer
L
- Liver Cancer
Liver cancer management is shaped by both tumour characteristics and underlying liver function.
Read more about Liver Cancer- Lung Cancer
Lung cancer is one of the areas where molecular characterisation has most changed clinical thinking, particularly in non-small cell histologies.
Read more about Lung Cancer
M
- Melanoma
Melanoma biology and treatment thinking have been substantially shaped by molecular and immune characterisation.
Read more about MelanomaRelated:Targeted therapyImmunotherapy
O
- Ovarian Cancer
Ovarian cancer includes several histological subtypes with different biology and clinical course.
Read more about Ovarian CancerRelated:Cancer geneticsTargeted therapy
P
- Pancreatic Cancer
Pancreatic cancer often presents late and remains challenging to treat, which makes careful individual assessment important.
Read more about Pancreatic Cancer- Prostate Cancer
Prostate cancer ranges from indolent disease to aggressive, treatment-resistant presentations.
Read more about Prostate CancerRelated:Hormone therapyCancer genetics
R
- Rare and Difficult-to-Treat Cancers
Rare tumours, cancers of unknown primary and treatment-refractory disease often benefit from careful, deliberate characterisation.
Read more about Rare and Difficult-to-Treat Cancers
S
- Sarcomas
Sarcomas are a heterogeneous group of rare tumours of soft tissue and bone.
Read more about Sarcomas
T
- Thyroid Cancer
Thyroid cancers range from indolent differentiated tumours to aggressive subtypes.
Read more about Thyroid Cancer
The A-Z directories provide general educational information. The relevance of a biomarker, test or therapy depends on the individual diagnosis and clinical context, and should be interpreted with a qualified healthcare professional. These descriptions are educational. They do not describe any individual diagnosis, stage, prognosis or treatment plan, and they are not a way of identifying which cancer someone has.
Other indexes
Continue browsing.
Understanding the terms is a starting point, not a plan.
A consultation places these findings in the context of an individual clinical situation.